110 related articles for article (PubMed ID: 471426)
1. Chemotherapeutic agents and estradiol receptor binding capacity.
Görlich M; Heise E; Számel I; Kerpel-Fronius S
Oncology; 1979; 36(4):149-55. PubMed ID: 471426
[TBL] [Abstract][Full Text] [Related]
2. The role of intracellular equilibria and the effect of antiestrogens on estrogen-receptor dissociation kinetics from perfused cultures of human breast cancer cells.
Strobl JS; Monaco ME; Lippman ME
Endocrinology; 1980 Aug; 107(2):450-60. PubMed ID: 7389663
[No Abstract] [Full Text] [Related]
3. Specific binding and biological response of antiestrogens in the fetal uterus of the guinea pig.
Gulino A; Pasqualini JR
Cancer Res; 1980 Oct; 40(10):3821-6. PubMed ID: 7438065
[TBL] [Abstract][Full Text] [Related]
4. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites.
Syne JS; Markaverich BM; Clark JH; Panko WB
Cancer Res; 1982 Nov; 42(11):4449-54. PubMed ID: 7127287
[TBL] [Abstract][Full Text] [Related]
5. Dephosphorylation of oestradiol nuclear receptor in vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens.
Auricchio F; Migliaccio A; Castoria G
Biochem J; 1981 Sep; 198(3):699-702. PubMed ID: 6275856
[TBL] [Abstract][Full Text] [Related]
6. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
7. Estradiol dependent decrease of binding inhibition by anti-estrogens (a possible test of receptor activation).
Rochefort H; Capony F
Biochem Biophys Res Commun; 1977 Mar; 75(2):277-85. PubMed ID: 557979
[No Abstract] [Full Text] [Related]
8. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions.
Nicholson RI; Syne JS; Daniel CP; Griffiths K
Eur J Cancer (1965); 1979 Mar; 15(3):317-29. PubMed ID: 446514
[No Abstract] [Full Text] [Related]
9. Contribution to the mechanism of Stilbostat action.
Görlich M; Heise E
Neoplasma; 1976; 23(4):363-9. PubMed ID: 1004653
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
Markaverich BM; Williams M; Upchurch S; Clark JH
Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
[TBL] [Abstract][Full Text] [Related]
11. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
Poortman J; Prenen JA; Schwarz F; Thijssen JH
J Clin Endocrinol Metab; 1975 Mar; 40(3):373-9. PubMed ID: 163841
[TBL] [Abstract][Full Text] [Related]
12. Effect of chemotherapeutic agents on the formation of estrogen-receptor complex in human breast tumor cytosol.
Müller RE; Sheard BE; Traish A; Wotiz HH
Cancer Res; 1980 Aug; 40(8 Pt 1):2941-2. PubMed ID: 7388845
[TBL] [Abstract][Full Text] [Related]
13. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
Attardi B; Palumbo LA
Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
[TBL] [Abstract][Full Text] [Related]
14. A simple modification of the estrogen receptor exchange assay: validation in nuclei from the rat uterus and a mouse mammary tumor.
Schoenberg DR; Clark JH
Endocrinology; 1980 Jan; 106(1):56-60. PubMed ID: 7349972
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells.
Wakeling AE; Valcaccia B; Newboult E; Green LR
J Steroid Biochem; 1984 Jan; 20(1):111-20. PubMed ID: 6538611
[TBL] [Abstract][Full Text] [Related]
16. Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.
Koenders AJ; Beex LV; Geurts-Moespot J; Benraad TJ
Eur J Cancer (1965); 1980; Suppl 1():63-6. PubMed ID: 7318871
[No Abstract] [Full Text] [Related]
17. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
Markaverich BM; Roberts RR; Alejandro MA; Clark JH
Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of estradiol receptors in rat uterine cytosol by sensitivity to tamoxifen.
Fishman JH; Fishman J
Biochem Biophys Res Commun; 1979 Mar; 87(2):550-8. PubMed ID: 444239
[No Abstract] [Full Text] [Related]
19. Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma.
Kawamura I; Mizota T; Mukumoto S; Manda T; Masuda K; Nakamura T; Kubota H; Matsumoto S; Nishigaki F; Shimomura K
Arzneimittelforschung; 1989 Aug; 39(8):889-93. PubMed ID: 2818677
[TBL] [Abstract][Full Text] [Related]
20. Different stability during incubation in vitro of the induced-protein (IP) response elicited in the rat uterus by treatment in vivo with oestradiol-17 beta or Nafoxidine [proceedings].
Mairesse N; Galand P
Arch Int Physiol Biochim; 1977 Dec; 85(5):1003-4. PubMed ID: 79342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
